Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MNPR Monopar Therapeutics

休市中 11-06 16:00:00 EST

71.42

+4.20

+6.25%

盘后73.00

+1.58+2.21%

19:45 EST

最高72.25	最低67.31	成交量9.42万
今开68.02	昨收67.22	日振幅7.35%
总市值4.77亿	流通市值3.20亿	总股本668.26万
成交额658.68万	换手率2.10%	流通股本447.78万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MNPR","market":"US","secType":"STK","nameCN":"Monopar Therapeutics","latestPrice":71.42,"timestamp":1793998800000,"preClose":67.22,"halted":0,"volume":94209,"hourTrading":{"tag":"盘后","latestPrice":73,"preClose":71.42,"latestTime":"19:45 EST","volume":2187,"amount":157137.2838,"timestamp":1794012353476,"change":1.58,"changeRate":0.022123,"amplitude":0.022123},"delay":0,"changeRate":0.0624814043439453,"floatShares":4477800,"shares":6682584,"eps":-2.180383,"marketStatus":"休市中","change":4.2,"latestTime":"11-06 16:00:00 EST","open":68.02,"high":72.25,"low":67.31,"amount":6586777.67985,"amplitude":0.07349,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.180383,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"listingDate":1576731600000,"exchange":"NASDAQ","adjPreClose":67.22,"preHourTrading":{"tag":"盘前","latestPrice":68.56,"preClose":67.22,"latestTime":"07:50 EST","volume":1,"amount":68.56,"timestamp":1793969440637,"change":1.34,"changeRate":0.019935,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":73,"preClose":71.42,"latestTime":"19:45 EST","volume":2187,"amount":157137.2838,"timestamp":1794012353476,"change":1.58,"changeRate":0.022123,"amplitude":0.022123},"volumeRatio":0.512043281459934},"requestUrl":"/m/hq/s/MNPR","defaultTab":"news","newsList":[{"id":"1116058303","title":"Monopar Therapeutics任命Jeffrey D. Kent医学博士为执行副总裁兼医学事务主管，并宣布两项ALXN1840研究将在AASLD 2026肝病年会上展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1116058303","media":"美股速递","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116058303?lang=zh_cn&edition=full","pubTime":"2026-08-19 20:01","pubTimestamp":1787140876,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics今日宣布两项重大进展：任命Jeffrey D. Kent医学博士为执行副总裁兼医学事务主管，同时披露其候选药物ALXN1840的两项研究摘要已被2026年美国肝病研究协会年会——即The Liver Meeting 2026——正式接收。与此同时，Monopar还公布了ALXN1840在肝病领域的两项临床前及临床研究摘要，均已获准在AASLD年会上进行口头或海报展示。Monopar Therapeutics是一家处于临床阶段的生物制药公司，专注于开发针对罕见病与肿瘤的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161055577","title":"Monopar Therapeutics 任命资深商业高管 Nicole Sweeny 加入董事会并扩充商业领导团队，以推进产品上市准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1161055577","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161055577?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:01","pubTimestamp":1784548875,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics 正积极推动其产品上市准备工作，通过任命资深商业高管 Nicole Sweeny 加入董事会，并同时扩充公司的商业领导团队。这一系列举措旨在强化公司的商业化战略与执行能力，为未来潜在产品的成功上市奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127266619","title":"Monopar Therapeutics 旗下Alxn1840获FDA罕见儿科疾病认定，用于治疗威尔逊病","url":"https://stock-news.laohu8.com/highlight/detail?id=1127266619","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127266619?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:03","pubTimestamp":1782821000,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics 公司宣布，其研发药物Alxn1840已获得美国食品药品监督管理局（FDA）授予的罕见儿科疾病认定，该药物拟用于治疗威尔逊病。\n这一认定标志着该疗法在针对这一罕见遗传性铜代谢障碍的儿科患者治疗开发中，取得了重要进展。罕见儿科疾病认定旨在激励针对严重影响儿童、患者数量稀少的严重和危及生命疾病的疗法开发。\nAlxn1840是一种旨在治疗威尔逊病的在研疗法。威尔逊病是一种罕见的遗传性疾病，会导致铜在身体各个器官（尤其是肝脏、大脑和眼睛）中异常积累，进而可能引发严重的肝脏和神经系统问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517947175","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.27%报30.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517947175?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:33","pubTimestamp":1741195992,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时33分，Monopar Therapeutics Inc.股票出现异动，股价大幅下跌5.27%。截至发稿，该股报30.03美元/股，成交量6589股，换手率0.11%，振幅6.21%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.29%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013312989d6e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013312989d6e8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634207","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634207?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012721,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分，Monopar Therapeutics Inc.股票出现波动，股价快速上涨6.10%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.70%、43.08%、31.69%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为27.57%、19.25%、18.04%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238419637ae43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238419637ae43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376347","title":"Monopar Therapeutics Inc.盘中异动 早盘急速拉升7.04%报32.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514376347?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:29","pubTimestamp":1740756552,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时29分，Monopar Therapeutics Inc.股票出现波动，股价快速拉升7.04%。截至发稿，该股报32.38美元/股，成交量1.8378万股，换手率0.30%，振幅3.87%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232912963426fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232912963426fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514852276","title":"Monopar Therapeutics Inc.盘中异动 大幅上涨5.24%报32.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514852276?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:48","pubTimestamp":1740584889,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时48分，Monopar Therapeutics Inc.股票出现波动，股价急速上涨5.24%。截至发稿，该股报32.74美元/股，成交量1.1134万股，换手率0.18%，振幅7.27%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623480996315e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623480996315e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513072065","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513072065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513072065?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409550,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Monopar Therapeutics Inc.股票出现异动，股价大幅下跌5.39%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为163.29%、71.43%、25.67%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230550a2521cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230550a2521cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512485959","title":"Monopar Therapeutics Inc.盘中异动 股价大跌7.62%报40.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512485959?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:59","pubTimestamp":1739977146,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时59分，Monopar Therapeutics Inc.股票出现异动，股价急速跳水7.62%。截至发稿，该股报40.76美元/股，成交量2170股，换手率0.04%，振幅0.84%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225906a24c015c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225906a24c015c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511627529","title":"Monopar Therapeutics Inc.盘中异动 早盘急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511627529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511627529?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:06","pubTimestamp":1739459179,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时06分，Monopar Therapeutics Inc.股票出现异动，股价快速下挫5.21%。截至发稿，该股报47.89美元/股，成交量5553股，换手率0.09%，振幅2.53%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230619abcdb8bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230619abcdb8bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510330545","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510330545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510330545?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:22","pubTimestamp":1739294530,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时22分，Monopar Therapeutics Inc.股票出现波动，股价快速下挫5.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，Omega Therapeutics, Inc.、Oramed Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3037.33%、1356.66%、447.02%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120122109881d9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120122109881d9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149424","title":"Monopar Therapeutics Inc.盘中异动 股价大跌11.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149424?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Monopar Therapeutics Inc.股票出现波动，股价急速下挫11.24%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为351.55%、306.17%、140.67%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223525a2380a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223525a2380a96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507162441","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨5.64%报40.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507162441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507162441?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:50","pubTimestamp":1738248605,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时50分，Monopar Therapeutics Inc.股票出现波动，股价快速上涨5.64%。截至发稿，该股报40.99美元/股，成交量5744股，换手率0.09%，振幅2.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225006abbd5020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225006abbd5020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506303573","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.91%报39.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506303573?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988352,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Monopar Therapeutics Inc.股票出现异动，股价大幅下挫5.91%。截至发稿，该股报39.01美元/股，成交量4428股，换手率0.07%，振幅1.09%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223232a2316aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223232a2316aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506867971","title":"Monopar Therapeutics Inc.盘中异动 早盘大幅上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506867971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506867971?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:45","pubTimestamp":1737733550,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时45分，Monopar Therapeutics Inc.股票出现波动，股价快速上涨5.57%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3660.40%、1893.42%、1403.54%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.，振幅分别为134.08%、112.09%、66.25%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242345509872114f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242345509872114f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045913","title":"Monopar Therapeutics Inc.盘中异动 临近午盘股价大涨5.26%报35.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505045913?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:32","pubTimestamp":1737649953,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时32分，Monopar Therapeutics Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报35.44美元/股，成交量2.062万股，换手率0.34%，振幅4.25%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003234a22d2318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003234a22d2318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505120580","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505120580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505120580?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:18","pubTimestamp":1737476310,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时18分，Monopar Therapeutics Inc.股票出现波动，股价急速上涨6.55%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Channel Therapeutics Corporation、Genelux Corporation、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为757.01%、474.40%、182.29%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001830960bcd6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001830960bcd6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504164055","title":"Monopar Therapeutics Inc.股价重挫10.20% 市值跌709.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504164055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504164055?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:39","pubTimestamp":1737124765,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时39分，Monopar Therapeutics Inc.股票出现异动，股价快速下跌10.20%。截至发稿，该股报27.37美元/股，成交量4844股，换手率0.08%，振幅8.80%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223925986a1708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223925986a1708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501773532","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501773532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501773532?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:31","pubTimestamp":1736346684,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时31分，Monopar Therapeutics Inc.股票出现波动，股价急速下跌5.15%。截至发稿，该股报23.87美元/股，成交量580股，换手率0.01%，振幅0.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223125aba34a9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223125aba34a9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495161937","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495161937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495161937?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:11","pubTimestamp":1735657918,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时11分，Monopar Therapeutics Inc.股票出现波动，股价急速下挫5.03%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，知临集团、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Eyenovia, Inc.涨幅较大，知临集团、Eyenovia, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1028.37%、216.96%、62.67%，振幅较大的相关个股有知临集团、Eyenovia, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为119.56%、65.84%、65.50%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231231158a210938c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231231158a210938c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.monopartx.com","stockEarnings":[{"period":"1week","weight":0.0156},{"period":"1month","weight":-0.1475},{"period":"3month","weight":-0.4009},{"period":"6month","weight":0.1234},{"period":"1year","weight":-0.1157},{"period":"ytd","weight":0.0937}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Monopar Therapeutics Inc.成立于2014年12月5日。该公司是一家临床阶段的生物制药公司，开发威尔逊病的创新治疗方法和肿瘤学的新型放射性药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.22612},{"month":2,"riseRate":0.285714,"avgChangeRate":0.090755},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.182533},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.03289},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.037743},{"month":6,"riseRate":0.714286,"avgChangeRate":0.099323},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.016558},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.131595},{"month":9,"riseRate":0.285714,"avgChangeRate":0.373822},{"month":10,"riseRate":0.428571,"avgChangeRate":0.175221},{"month":11,"riseRate":0.714286,"avgChangeRate":0.042521},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.031256}],"exchange":"NASDAQ","name":"Monopar Therapeutics","nameEN":"Monopar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Monopar Therapeutics,MNPR,Monopar Therapeutics股票,Monopar Therapeutics股票老虎,Monopar Therapeutics股票老虎国际,Monopar Therapeutics行情,Monopar Therapeutics股票行情,Monopar Therapeutics股价,Monopar Therapeutics股市,Monopar Therapeutics股票价格,Monopar Therapeutics股票交易,Monopar Therapeutics股票购买,Monopar Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}